Market capitalization | $873.28m |
Enterprise Value | $858.02m |
EV/Sales (TTM) EV/Sales | 12.25 |
P/S ratio (TTM) P/S ratio | 12.46 |
Dividend yield | 11.74% |
Last dividend (FY24) | $2.04 |
Revenue growth (TTM) Revenue growth | -13.77% |
Revenue (TTM) Revenue | $70.07m |
EBIT (operating result TTM) EBIT | $72.88m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
Mar '24 |
+/-
%
|
||
Revenue | 70 70 |
14%
14%
|
|
Gross Profit | 60 60 |
15%
15%
|
|
EBITDA | 73 73 |
1,731%
1,731%
|
EBIT (Operating Income) EBIT | 73 73 |
1,731%
1,731%
|
Net Profit | 73 73 |
1,731%
1,731%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.
Head office | United States |
Founded | 1986 |
Website | www.teklacap.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.